| B6 | Evaluation of new high-throughput platforms for the quantification of HIV-1 RNA in plasma to support scale-up of viral load testing in low- and middle-income countries | On-demand oral abstract session | Viral load and CD4 measurement |
| B35 | APOBEC editing in HIV DNA proviral vif and pol long-reads issued from virologically-suppressed patients included in the ANRS LAMIDOL trial | On-demand oral abstract session | Regimen simplification and switch studies |
| B27 | HIV immune reconstitution inflammatory response syndrome and the risk of adverse pregnancy-fetal outcomes among ART naïve women aged 20-49 years in selected public hospitals, Nairobi, Kenya | On-demand oral abstract session | Immune reconstitution disorders and immune reconstitution inflammatory syndrome |
| B19 | Factors associated with severity of Edinburgh Postnatal Depression Screen (EPDS) and optimal cut-off of EPDS for diagnosis of depression and anxiety among postpartum HIV- positive women in Lusaka, Zambia | On-demand oral abstract session | Depression and other psychiatric manifestations |
| B24 | Longitudinal study on insulin resistance and metabolic syndrome in children with perinatal HIV infection and HIV exposed uninfected children in South Africa | On-demand oral abstract session | Metabolic, lipid and endocrine complications (including obesity, hyperlipidaemia and lipodystrophy) |
| B62 | The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence | On-demand oral abstract session | ARV management strategies in paediatric and adolescent populations |
| B67 | Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial | On-demand oral abstract session | Mental health and neurocognition in paediatric and adolescent populations |
| C27 | Global adoption of guidelines on and use of oral pre-exposure prophylaxis (PrEP): current situation and future projections | On-demand oral abstract session | PrEP |
| C27 | Early predictors of seroconversion among enrolees in a PrEP program in Brazil, Mexico and Peru ' the IMPREP Demonstration study | On-demand oral abstract session | PrEP |
| C27 | Comparing adherence to HIV Pre-Exposure Prophylaxis (PrEP) among new, male PrEP users initiating F/TAF vs. F/TDF | On-demand oral abstract session | PrEP |